Robert J. Mears - 01 Jun 2023 Form 4 Insider Report for Atomera Inc (ATOM)

Signature
/s/ Robert J. Mears, by Mindi Zimmer, as Attorney-in-Fact
Issuer symbol
ATOM
Transactions as of
01 Jun 2023
Transactions value $
-$89,645
Form type
4
Filing time
02 Jun 2023, 17:38:32 UTC
Previous filing
03 Mar 2023
Next filing
05 Sep 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATOM Common Stock Sale -$8,505 -945 -0.72% $9 129,541 01 Jun 2023 Direct F1
transaction ATOM Common Stock Sale -$2,241 -249 -0.19% $9 129,292 01 Jun 2023 Direct F1
transaction ATOM Common Stock Sale -$4,545 -505 -0.39% $9 128,787 01 Jun 2023 Direct F1
transaction ATOM Common Stock Sale -$1,062 -118 -0.09% $9 128,669 01 Jun 2023 Direct F1
transaction ATOM Common Stock Options Exercise $39,000 +10,000 +7.77% $3.9 138,669 01 Jun 2023 Direct F2
transaction ATOM Common Stock Sale -$88,100 -10,000 -7.21% $8.81 128,669 01 Jun 2023 Direct F2
transaction ATOM Common Stock Sale -$24,192 -2,800 -2.18% $8.64 125,869 02 Jun 2023 Direct F2
holding ATOM Common Stock 2,666 01 Jun 2023 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOM Non-Qualified Stock Option (right to buy) Options Exercise $0 -10,000 -21.31% $0 36,923 01 Jun 2023 Common Stock 10,000 $3.9 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants that were previously reported. This sale is to satisfy mandatory non-discretionary tax withholding obligations by a "sell to cover" transaction.
F2 This transaction is part of a 10b5-1 plan adopted on July 8, 2022 by the Reporting Person.